Lucid-MS

3 articles
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quantum BioPharma Grants 35,000 Stock Options to Retain Talent

Quantum BioPharma grants 35,000 stock options to employees at CA$6.50 strike, vesting immediately with five-year exercise window.
QNTMclinical trialbiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quantum BioPharma Adjusts Debenture Terms Amid Share Price Decline

Quantum BioPharma revises debenture offering terms following share price decline, lowering conversion price to $3.00 and increasing warrant allocation.
QNTMwarrantsbiopharmaceutical
GlobeNewswire Inc.GlobeNewswire Inc.··Na

Quantum BioPharma Launches $4M Convertible Offering to Fund Operations

Quantum BioPharma raises capital through convertible debentures and debt-to-equity conversion to strengthen balance sheet and fund business development.
QNTMprivate placementcapital raising